← Back to Search

Treatment for Infant Development (BabyEE Pilot Trial)

N/A
Recruiting
Led By Leanne M Redman, Ph.D.
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 1 week
Awards & highlights

Summary

The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.

Eligible Conditions
  • Infant Development
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 1 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Energy Expenditure by infant metabolic chamber
Energy expenditure by doubly labeled water
Secondary study objectives
Percent body fat
Physical activity counts

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,409 Previous Clinical Trials
4,324,849 Total Patients Enrolled
Pennington Biomedical Research CenterLead Sponsor
307 Previous Clinical Trials
181,101 Total Patients Enrolled
1 Trials studying Infant Development
171 Patients Enrolled for Infant Development
Leanne M Redman, Ph.D.Principal InvestigatorPennington Biomedical Research Center
8 Previous Clinical Trials
804 Total Patients Enrolled
~1 spots leftby Dec 2024